Pharmacy and Therapeutics (P&T) Committee

The Pharmacy and Therapeutics (P&T) Committee is an advisory board established pursuant to Executive Order D004-07. The committee performs clinical reviews of drug classes and makes recommendations which help the Department develop and manage the Medicaid Preferred Drug List (PDL).

The P&T Committee is required to consider clinical criteria such as drug safety and efficacy when making its recommendations. The committee also considers public comments and testimony related to the drug classes being reviewed or other PDL-related agenda items.

2022 Meeting Schedule and Handouts

Our meeting has been changed to virtual. The meeting link will be posted just prior to the meeting for public attendees.

1:00 p.m. - 5:00 p.m.

The Committee meets once quarterly in January, April, July, and October.

October 4, 2022

MEETING HAS CHANGED TO A VIRTUAL MEETING

 

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

  • Agenda / Minutes
  • Preferred Drug List Drug Class Review Announcement
July 12, 2022

MEETING HAS CHANGED TO A VIRTUAL MEETING

 

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

  • Agenda / Minutes
  • Preferred Drug List Drug Class Review Announcement
April 12, 2022

MEETING HAS CHANGED TO A VIRTUAL MEETING

 

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

  • Agenda / Minutes
  • Preferred Drug List Drug Class Review Announcement
January 11, 2022

MEETING HAS CHANGED TO A VIRTUAL MEETING

 

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

  • Agenda / Minutes
  • Preferred Drug List Drug Class Review Announcement

2021 Meeting Schedule and Handouts

Our meeting has been changed to virtual. The meeting link will be posted just prior to the meeting for public attendees.

1:00 p.m. - 5:00 p.m.

The Committee meets once quarterly in January, April, July, and October.

October 5, 2021

MEETING HAS CHANGED TO A VIRTUAL MEETING

 

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

July 13, 2021

MEETING HAS CHANGED TO A VIRTUAL MEETING

 

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

April 13, 2021

MEETING HAS CHANGED TO A VIRTUAL MEETING

 

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

January 12, 2021

MEETING HAS CHANGED TO A VIRTUAL MEETING

 

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

2020 Meeting Schedule and Handouts 

Our meeting has a new location: 303 E. 17th Ave, Denver, Colorado 80203

1:00 p.m. - 5:00 p.m.

The Board meets once quarterly in January, April, July, and October

October 6, 2020

MEETING HAS CHANGED TO A VIRTUAL MEETING

 

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

July 14, 2020

MEETING HAS CHANGED TO A VIRTUAL MEETING

 

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

April 7, 2020

MEETING HAS CHANGED TO A VIRTUAL MEETING

 

It is recommended to register in advance. The webinar will open 5 minutes prior to 1:00 p.m. MST and will be recorded. Updated agenda also contains webinar details.

January 7, 2020

MEETING WILL TAKE PLACE ON THE 11TH FLOOR IN CONFERENCE ROOMS 11ABC

Our Members 

The P&T Committee consists of 7 physicians, 4 pharmacists and 2 client representatives, who are appointed by the Department's Executive Director. Review the Policies and Procedures Manual for more information on the committee's membership, duties and policies.

January 2020 - December 2021 Term

Lynn Parry, MD

Gwen Black, PharmD

Marisa Wiktor, MD

Kelet Robinson, MD

Thuy McKitrick, PharmD

Davin Patel, PharmD

January 2021 - December 2022 Term

James Feinstein, MD

Kimberley Jackson, DO

David Elwell, MD

Emily Kosirog, PharmD

Daralyn Morgenson, PharmD

Contact Us/Join Us

Program Administrator

Brittany Schock, PharmD
Colorado Department of Health Care Policy and Financing
1570 Grant Street
Denver, CO 80203
Phone: 303-866-6371
 

Openings for New Members

Pharmacy & Therapeutics (P&T) Committee Open Positions Applicants are being accepted for the following two open positions for the P&T Committee member term ending in December 2022:

  • One physician who specializes in the practice of psychiatry
  • One physician who specializes in the treatment of members with disabilities

Applicants are being accepted for the following six open positions for the P&T Committee member terms January 2022 - December 2023:

  • Pharmacist (2 positions)
  • Specialty Physician (3 positions)
  • Member Representative (1 position)

The actively practicing pharmacist, physician, or member representative shall serve two-year terms. Duties, membership and other term details can be found in the P&T Committee Policies and Procedures.

If interested in serving or know someone who would be qualified, please submit/have them submit a CV along with a completed Conflict of Interest form by October 22, 2021, to:

Colorado Department of Health Care Policy and Financing
Attn: Brittany Schock, PharmD
Fax to 303-866-3590 or email Brittany.Schock@state.co.us

A CV is not required for the member representative position. A resume (or similar document) is acceptable.

Presenting Testimony

Interested parties who want to present at the meeting shall give at least 3 business days notice (by 5 p.m. MST), prior to the meeting, to Jessica Czechowski, Clinical Account Manager, by email at jlczechowski@magellanhealth.com and carbon copy Brittany Schock, PDL Pharmacist, by email at brittany.schock@state.co.us. Please see the specific deadline for testimony on the meeting agenda.

Please see the P&T Committee Policies and Procedures for both written and verbal comments.

Reasonable accommodations for the meetings will be provided upon request for persons with disabilities. Please contact the Program Administrator at least one week prior to the scheduled meeting if you need special arrangements.